Searchable abstracts of presentations at key conferences in endocrinology

ea0044p210 | Reproduction | SFEBES2016

Safety and tolerability of inducing completion of puberty with IM testosterone over 1 year in older men with congenital hypogonadism and absent puberty

Pazderska Agniezska , Artham Satish , Miller Margaret , Morris Margaret , Ball Steve , Quinton Richard

Background: Guidance on pubertal-induction in hypogonadal adult men is sparse. For adolescent boys, in whom delay is usually constitutional, treatment is typically initiated with pulsed low-dose IM testosterone (T); the dose being progressively increased if/when it becomes clear that endogenous gonadotrophin secretion is not being initiated. In teenagers with organic hypogonadism, the aims are to recapitulate the normal tempo of puberty over 2–3 years and optimise linear ...

ea0038p43 | Clinical practice/governance and case reports | SFEBES2015

What is the prevalence of severe post-operative hypocalcaemia in patients who have undergone parathyroid surgery or a total thyroidectomy at the RVI, Newcastle? Does vitamin D play a role?

Pawlak Anna , Quinton Richard , Truran Peter , Lennard Thomas , Bliss Richard , Heed Andrew

Background: Hypocalcaemia is a common electrolyte disorder and it can occur following parathyroidectomy or thyroidectomy. It has been suggested that some post-operative hypocalcaemic crises may reflect severe vitamin D deficiency and vitamin D supplementation may have a protective effect.Objectives: To establish the prevalence of severe post-operative hypocalcaemia (as defined by the requirement for i.v. calcium gluconate) following parathyroid surgery a...

ea0028oc1.1 | Young Endocrinologists prize session | SFEBES2012

Functional characterisation and translational clinical applications of kisspeptin-10

George Jyothis , Quinton Richard , Young Jacques , Veldhuis Johannes , Millar Robert , Anderson Richard

Hypothesis: Exogenous kisspeptin-10 (Kp10) enhances pulsatile LH. Research strategy: A first-in-man dosing study of kp10 was first performed. Healthy volunteers and hypogonadal patients were subsequently infused with kp10. Dose titration study Rapid increases in LH with clear dose-dependency (P<0.0001) were observed in healthy men (n=6), with the 0.3 and 1 µg/kg doses being maximally stimulatory (P<0.01). Effect of sex-steroid milieu: LH respo...

ea0028p21 | Bone | SFEBES2012

An audit of vitamin D status among local multiple sclerosis patients

Lim Yuen Han , Pattman Stewart , Guadagno Joe , Duddy Martin , Smith Gillian , Wilkinson Carmel , Quinton Richard

Background: Multiple sclerosis (MS) is associated with low ambient ultraviolet B (UVB) light in childhood and in utero (relative risk of developing MS is 1.2 for those born in spring). Besides, the MS-linked HLA-DRB1 allele interacts strongly with vitamin D in vitro, and vitamin D levels are lower in MS patients. Fatigue and musculoskeletal aches/pains are prominent symptoms in both MS and vitamin D deficiency. Moreover, having any chronic disease may predispose to stay...

ea0019p44 | Clinical practice/governance and case reports | SFEBES2009

Lessons from a case of pituitary thyrotrophinoma I: not all TSH-omas are macroadenomas II: thyroid autoimmunity can be associated III: associated central hyperthyroidism can be subclinical

Arutchelvam V , Neely RDG , Mitra D , Hill J , Carrie S , Gurnell M , Quinton R

A 64-year-old lady presented with weight gain, tiredness, palpitations and tremor. She had no goitre and no other extra thyroidal manifestations. Both TSH and thyroid peroxidase antibodies (>1300) were elevated and she was treated by her GP with Thyroxine 50 mcg daily. She felt a lot worse on this, so it was discontinued and a full thyroid hormone profile was checked (see Table 1) which prompted referral; to Endocrinology.Other pituitary hormone leve...

ea0015p92 | Clinical practice/governance and case reports | SFEBES2008

Extreme delay in presentation of congenital adrenal hyperplasia in a male with CYP21A2 deficiency

Arutchelvam Vijayaraman , Ravikumar Balasubramaniyam , Advani Andrew , Pearce Simon HS , Taylor Roy , Forrest Ian , Quinton Richard

Introduction: Congenital adrenal hyperplasia (CAH) is an inherited disorder, most commonly caused by enzymatic deficiency of 21-hydroxylase (CYP21A2). The non-classic or late-onset form is one of the most common autosomal recessive diseases in women, but the diagnosis is only rarely made in men unless they happen to present with testicular or adrenal masses or infertility.Case report: A 65-year-old man presented with recurrent episodes of postural dizzin...

ea0013p220 | AMEND Young Investigator's Award | SFEBES2007

Diagnosing early acromegaly: the pre-test probability of disease is strongly influenced by the presence or absence of other associated diseases

Bhattacharya Beas , Syed Akheel , Razvi Salmon , Johnson K , Hill J , Carrie S , Mitra D , Quinton Richard

A 44-year-old man referred with erectile dysfunction was found to have hypogonadotrophic hypogonadism (HH), but otherwise apparently normal anterior pituitary function (LH 1.6 & FSH 2.7 IU/l; T 3.4 & cortisol 516 nmol/l; PRL 103, GH 5.5 & TSH 2.8 mU/l; f-T4 13, f-T3 4.8 & f-T 128 pmol/l; ferritin 103 ug/l). He appeared normally virilised, with central obesity (BMI 36 kg.m−2, collar size 46 cm) and symptomatic sleep apnoea (SA). MRI showed a rig...

ea0013p259 | Reproduction | SFEBES2007

Use of long-acting intramuscular testosterone undecanoate depot (Nebido) in men with organic severe hypogonadism: initial experience from a UK tertiary referral centre

Ravikumar Balasubramanian , Miller Margaret , James RA , Ball SG , Pearce SHS , Quinton Richard

Conventional intramuscular preparations of testosterone esters are associated with wide fluctuations in serum testosterone (T) levels following administration, even when a lower dose (100 mg) is injected every 7–10 days, let alone 250 mg every 2–3 weeks. Depot Testosterone undecanoate [TU -Nebido] is a newly available option for androgen replacement. The possibility of achieving stable therapeutic serum T levels over a period of months is its principal attraction. Da...

ea0012oc21 | Pituitary, ovary and steroids | SFE2006

Macroprolactinoma with progressive resistance to high-dose cabergoline

Arun CS , Mitra Dip , Ball Steve , Hill John , Lewis Joanna , Quinton Richard

IntroductionTrue resistance to cabergoline in patients with hyperprolactinaemia has only rarely been reported. We describe a patient with macroprolactinoma who initially responded to cabergoline, but then developed a progressive increase in PRL levels.Clinical caseA 78-year-old male presenting with headache and left temporal hemianopia was found to have a macroprolactinoma with suprasellar/cavernous sinus ext...

ea0011oc22 | Clinical endocrinology | ECE2006

Detection of phaeochromocytoma: The emerging role of plasma metanephrines

Peaston RT , Ball SG , Quinton R , James RA , Pearce S , Lennard TWJ , Neely RDG

Phaeochromocytomas (PCC) are rare neuroendocrine tumours of chromaffin cells that are characterised by autonomous production of catecholamines. Fundamental to the detection and diagnosis is the biochemical confirmation of excessive catecholamine production by the measurement of plasma or urinary catecholamines and metanephrines. Recently, plasma metanephrines have been shown to provide a high diagnostic sensitivity for the detection of catecholamine secreting tumours and unlik...